GL1X · GenesisL1 explorer

Research workbench

Human retinal variant IMPDH1(595) treated with GTP, ATP, imp, NAD+, octamer-centered

Analyse Human retinal variant IMPDH1(595) treated with GTP, ATP, imp, NAD+… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7RGD
Type
protein
Length
4,152 residues
Chains
8
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Ligands
GTP, ATP, IMP, NAD

Structure

electron microscopy · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, E, F, G, H—protein519——

Ligands and binding sites

  • GTP · Guanosine-5'-triphosphate · ligand · 16 copies · chains A, B, C, D, E, F, G, H
  • ATP · Adenosine-5'-triphosphate · ligand · 8 copies · chains A, E, B, H, C, G, D, F
  • IMP · Inosinic acid · ligand · 8 copies · chains A, B, C, D, E, F, G, H
  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 8 copies · chains A, B, C, D, E, F, G, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7RGD · Human retinal variant IMPDH1(595) treated with GTP, ATP, imp, NAD+, octamer-centered · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.